Layered double hydroxide nanostructures as drug-carriers in treatment of breast cancer
نویسندگان
1 Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
2 Molecular Medicine Research Center, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran
3 Department of Radiation Oncology, Tabriz International Hospital, Tabriz, Iran
4 Pharmaceutical Analysis Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
5 Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
6 Department of Molecular Medicine, Faculty of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran
7 Clinical Research Development Unit of Sina Educational, Research and Treatment Center, Tabriz University of Medical Sciences, Tabriz, Iran
8 Food and Drug Safety Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
doi
10.22038/nmj.2022.63097.1661چکیده
Breast cancer is a public health problem globally and is the most frequent cancer world wide. Currently, anti-inflammatory and anti-cancer drugs are of prime interest in treating some cancers especially breast cancer and have become an exciting challenge for researchers. The use of layered structures consisting of anions and cations called layered double hydroxides (LDHs) has attracted the attention of many researchers in the field of biomedical and pharmaceuticals. LDHs-nanostructures can be used as drug carriers, especially anti-inflammatory and anti-cancer drugs to treat cancers. Thus, the LDHs should have a number of physicochemical properties to act as a desirable drug carrier. Among the primary factors to increase the efficiency of LDHs are their surface characteristics and size, number and type of ions, rapid clearance from the body after drug release, and non-toxicity. All of these properties make LDHs nano-carriers for carrying anti-inflammatory and anti-cancer drugs to treat a variety of cancers. Therefore, we focus on reviewing the nature of LDH nano-carriers and evaluating the desirable properties for drug delivery, drug loading methods into LDH and anti-inflammatory drug delivery methods, their potential applications in biomedical and their toxicity and antimicrobial effects in breast cancer.
